Syngene - Clinical Development

years of track record in supporting IND/NDA/BLA/ANDA submissions in regulated markets. Syngene’s staff comprises of over 2200 multi-disciplinary scientists are well-qualified and trained. Syngene provides full-service solutions for clinical development solutions of novel drugs and biosimilars, our experience encompasses bioequivalence studies on generic drugs, and in providing comprehensive range of laboratory services. While we have a long track record of evaluating the safety and efficacy of new drugs across a wide range of therapeutic indications, our expertise lies in oncology, diabetes and metabolic disorders. Syngene has vast clinical trial and project management expertise, having conducted complex clinical development programs of biologics, small molecules, vaccines and medical device, and completed them within the time and cost constraints laid out by the sponsors. We pride ourselves in "delighting" several domestic and overseas clients, which was made possible by our methodical, well-honed project management systems. We focus on quality and add value to our clients' clinical development programs by evolving various strategies to ensure timely execution of clinical projects within budget. We have been audited by several international clients as well as independent auditors and regulatory agencies.